1. Anonymous. Results announcement for the third quarter 2010 (GlaxoSmithKline, London)
http://www.gsk.com/investors/reports/q32010/q32010.pdf
(21 October 2010).
2. Anonymous. NICE rebuffs Tarceva. BioCentury Extra, p.3 (16 June 2010).
3. PricewaterhouseCoopers. Pharma 2020, Virtual R&D, Which Path Will You Take? (PricewaterhouseCoopers, New York City, 2008).
4. Spek, H. CLSA Healthcare Forum, New York, December 1, 2010.
http://en.sanofi-aventis.com/binaries/EM_conference_Spek_Web_tcm28-29638.pdf
5. Shaffer, C. Nat. Biotechnol. 28, 881–882 (2010).